| id |
ndltd-NEU--neu-rx9181521
|
| record_format |
oai_dc
|
| spelling |
ndltd-NEU--neu-rx91815212021-05-28T05:22:26ZIntranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammationNeurodegenerative diseases are the most prevalent brain diseases affecting more than 5.5 million people worldwide. If left unconstrained, 30 years from now, more than 12 million Americans will suffer from these diseases. neuro-inflammation has been one of the common denominator in broad spectrum of neurodegenerative diseases, such as Alzheimer's, Parkinson's, Sclerosis, and age-related macular degeneration diseases. Prevention and cure of these brain diseases has been facing outstanding challenge due the limited delivery of pharmacological therapeutics to the brain primarily due to presence of blood-brain barrier (BBB), blood-CSF barrier and expression of efflux transporters.http://hdl.handle.net/2047/D20198907
|
| collection |
NDLTD
|
| sources |
NDLTD
|
| description |
Neurodegenerative diseases are the most prevalent brain diseases affecting more than 5.5 million people worldwide. If left unconstrained, 30 years from now, more than 12 million Americans will suffer from these diseases. neuro-inflammation has been one of the common denominator in broad spectrum of neurodegenerative diseases, such as Alzheimer's, Parkinson's, Sclerosis, and age-related macular degeneration diseases. Prevention and cure of these brain diseases has been facing
outstanding challenge due the limited delivery of pharmacological therapeutics to the brain primarily due to presence of blood-brain barrier (BBB), blood-CSF barrier and expression of efflux transporters.
|
| title |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| spellingShingle |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| title_short |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| title_full |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| title_fullStr |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| title_full_unstemmed |
Intranasal delivery for peptide and siRNA to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| title_sort |
intranasal delivery for peptide and sirna to the brain using lipid-based nanocarriers for the treatment of neuroinflammation
|
| publishDate |
|
| url |
http://hdl.handle.net/2047/D20198907
|
| _version_ |
1719408008797093888
|
